These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1600854)

  • 1. Risk factors for progression of microvascular complications in the Stockholm Diabetes Intervention Study (SDIS).
    Reichard P
    Diabetes Res Clin Pract; 1992 May; 16(2):151-6. PubMed ID: 1600854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
    Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
    Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.
    Ohkubo Y; Kishikawa H; Araki E; Miyata T; Isami S; Motoyoshi S; Kojima Y; Furuyoshi N; Shichiri M
    Diabetes Res Clin Pract; 1995 May; 28(2):103-17. PubMed ID: 7587918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years.
    Reichard P; Berglund B; Britz A; Cars I; Nilsson BY; Rosenqvist U
    J Intern Med; 1991 Aug; 230(2):101-8. PubMed ID: 1865159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with diabetic microangiopathy: a study of 157 type I (insulin-dependent) diabetic patients.
    Billault BM; Passa PL
    J Diabet Complications; 1991; 5(4):238-43. PubMed ID: 1779019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence and interrelationships of complications in insulin-dependent diabetes in Finland.
    Ebeling P; Koivisto VA
    Acta Diabetol; 1997 Mar; 34(1):33-8. PubMed ID: 9134055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are there any glycemic thresholds for the serious microvascular diabetic complications?
    Reichard P
    J Diabetes Complications; 1995; 9(1):25-30. PubMed ID: 7734740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications in IDDM are caused by elevated blood glucose level: the Stockholm Diabetes Intervention Study (SDIS) at 10-year follow up.
    Reichard P; Pihl M; Rosenqvist U; Sule J
    Diabetologia; 1996 Dec; 39(12):1483-8. PubMed ID: 8960830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood glucose control and microvascular complications--what do we do now?
    Dahl-Jørgensen K; Brinchmann-Hansen O; Bangstad HJ; Hanssen KF
    Diabetologia; 1994 Dec; 37(12):1172-7. PubMed ID: 7895945
    [No Abstract]   [Full Text] [Related]  

  • 11. The relationship of prorenin values to microvascular complications in patients with insulin-dependent diabetes mellitus.
    Davies L; Fulcher GR; Atkins A; Frumar K; Monaghan J; Stokes G; Clifton-Bligh P; McElduff A; Robinson B; Stiel J; Twigg S; Wilmshurst E
    J Diabetes Complications; 1999; 13(1):45-51. PubMed ID: 10232709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Stockholm Diabetes Intervention Study (SDIS): 18 months' results.
    Reichard P; Britz A; Cars I; Nilsson BY; Sobocinsky-Olsson B; Rosenqvist U
    Acta Med Scand; 1988; 224(2):115-22. PubMed ID: 3048052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relevance of persistent C-peptide secretion in type 1 (insulin-dependent) diabetes mellitus to glycaemic control and diabetic complications.
    Winocour PH; Jeacock J; Kalsi P; Gordon C; Anderson DC
    Diabetes Res Clin Pract; 1990 Apr; 9(1):23-35. PubMed ID: 2351037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between HbA1c Variability and Risk of Microvascular Complications in Adolescents With Type 1 Diabetes.
    Virk SA; Donaghue KC; Cho YH; Benitez-Aguirre P; Hing S; Pryke A; Chan A; Craig ME
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3257-63. PubMed ID: 27186858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus.
    Ak G; Buyukberber S; Sevinc A; Turk HM; Ates M; Sari R; Savli H; Cigli A
    J Diabetes Complications; 2001; 15(3):150-7. PubMed ID: 11358684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood glucose control and diabetic microvascular complications: long-term effects of near-normoglycaemia.
    Hanssen KF; Bangstad HJ; Brinchmann-Hansen O; Dahl-Jørgensen K
    Diabet Med; 1992 Oct; 9(8):697-705. PubMed ID: 1395460
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of pregnancy on IDDM complications.
    Hemachandra A; Ellis D; Lloyd CE; Orchard TJ
    Diabetes Care; 1995 Jul; 18(7):950-4. PubMed ID: 7555555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between smoking and microvascular complications in the EURODIAB IDDM Complications Study.
    Chaturvedi N; Stephenson JM; Fuller JH
    Diabetes Care; 1995 Jun; 18(6):785-92. PubMed ID: 7555504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycated hemoglobin variability and microvascular complications in patients with type 1 diabetes mellitus.
    Er E; Ata A; Evin F; Altınok YA; Demir G; Özen S; Darcan Ş; Gökşen D
    J Pediatr Endocrinol Metab; 2020 Dec; 33(12):1533-1537. PubMed ID: 33581707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating plasma vascular endothelial growth factor and microvascular complications of type 1 diabetes mellitus: the influence of ACE inhibition.
    Chaturvedi N; Fuller JH; Pokras F; Rottiers R; Papazoglou N; Aiello LP;
    Diabet Med; 2001 Apr; 18(4):288-94. PubMed ID: 11437859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.